Nephro Care India IPO aims to raise ₹41.26 crores. The IPO is open for subscription from June 28, 2024, and closed on July 2, 2024. The Nephro Care IPO allotment is set to be finalised today.
If you applied for the IPO, here is how you can check the Nephro Care IPO allotment status.
Checking Allotment Status on Registrar's Website:
Follow these steps to check the Nephro Care IPO allotment status
- Visit the registrar's website.
- Click on "Company Selection" and choose "Nephro Care" from the dropdown menu.
- Then you can enter your PAN, application number, or Demat.
- Click Submit to retrieve the Nephro Care IPO allotment status
If all the details are entered correctly and the allotment has been finalised, the Nephro Care IPO allotment status will be visible.
Nephro Care IPO Subscription Status
The Nephro Care India IPO has received overwhelming demand from investors. On the final day of bidding, the IPO was subscribed 715 times overall. Here’s the breakdown of the subscription across different categories:
- Retail Investor Category: Subscribed 634 times
- Qualified Institutional Buyers (QIB) Category: Subscribed 245 times
- Non-Institutional Investors (NII) Category: Subscribed 1,787 times
The IPO received bids for 223 crore shares compared to the 31.15 lakh shares that were on offer. This indicates strong investor interest and oversubscription across all investor categories.
See Also: RVNL Gears Up To Finish 2 Piers Near Metropolitan In Kolkata By August
Nephro Care IPO GMP
The Nephro Care IPO GMP is currently reported at ₹180. This is an increase from the ₹155 reported earlier. With the price band set at ₹90, the estimated listing price is ₹270, indicating a potential gain of 200% per share. However, it's crucial to remember that GMPs are merely indicative and should not be the sole factor in predicting a stock's performance upon listing.
Nephro Care IPO Details
The issue, comprising a fresh issue of 45.84 lakh shares, has a price band set at ₹85 to ₹90 per share. The minimum lot size for an application is 1600 shares, requiring a minimum investment of ₹144,000 by retail investors. The net proceeds from the offering will be used to set up a Multi-Speciality Hospital in Kolkata, West Bengal, and address general corporate expenses.
Before the IPO launch, the company secured ₹11.15 crores from anchor investors, allotting 12,38,400 equity shares at ₹90 per share. The anchor book saw participation from CCV Emerging Opportunities Fund – I, Persistent Growth Fund – Varsu India Growth Story Scheme 1, and Vikasa India EIF I Fund – Incube Global Opportunities. The allotment for the Nephro Care IPO is expected to be finalized on Wednesday, July 3, 2024, with shares tentatively scheduled to be listed on the NSE SME on Friday, July 5, 2024.
About Nephro Care India
Established in 2014, Nephro Care India Limited is a comprehensive treatment centre based in Kolkata. The facility offers a wide range of clinical and lifestyle solutions, along with renal insufficiency treatments for patients. Serving around 900 Chronic Kidney Disease patients each month, healthcare services are provided from its main Salt Lake clinic and three satellite clinics located in West Bengal.
Read Next: HCLTech Launches Global Delivery Centre In Patna
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.